ADIPOQ and metabolic syndrome: On the other side, metabolic comorbidities significantly affected patients with obesity; we observed that lower plasma adiponectin levels were associated with dyslipidemia, hypertension, and diabetes, regardless of sex (Figure 4b and Supplementary Figure S7b).